University Hospital 12 de Octubre Reports Findings in Artificial Intelligence (Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms)
University Hospital 12 de Octubre Reports Findings in Artificial Intelligence (Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms)
扫码查看
点击上方二维码区域，可以放大扫码查看
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News – New research on Artificial Intelligence is the su bject of a report. According to news reporting originating in Madrid, Spain, by NewsRx journalists, research stated, “To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TILs) in patients with early-stage non-small cell lung carcinoma (NSCLC) with artificial intelligence (AI) algorithms. The study included samples from 50 early-stage NSCLCs.”
Key words
Madrid/Spain/Europe/Algorithms/Artificial Intelligence/Blood Cells/Bronchial Neoplasms/Bronchogenic Carcinoma/Cancer/Carcinomas/Emerging Technologies/Health and Medicine/Hemic and Immune Systems/Immunology/Lung Diseases and Conditions/Lung Neoplasms/Lymphocytes/Machine Learning/Mononuclear Leukocytes/Non-Small Cell Lung Cancer/Non-Small- Cell Lung Cancer/Oncology/Pathology/Respiratory Tract Diseases and Conditions/Respiratory Tract Neoplasms/Small Cell Carcinoma/Small Cell Lung Cancer
NETL
NSTL